Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products.
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
Ashish
A
Sharma
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
Benjamin
B
Weber
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
Martina
M
Wein
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
Christoph
C
Hallmann
College of Pharmacy, University of Tennessee, Memphis, TN, USA.
Bernd
B
Meibohm
D001993:Bronchodilator Agents; D001239:Inhalation; D012602:Scopolamine Derivatives; D013810:Therapeutic Equivalency; D000069447:Tiotropium Bromide / Q000494:pharmacology*
D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide
COPD; asthma; equivalence; pharmacokinetics; tiotropium bromide